Weijian Pharmaceutical Group Co.
Weijian Pharmaceuticals is a new pharmaceutical company that promotes the development of China's pharmaceutical health industry
About Weijian Pharmaceutical Group Co.
Winhealth Pharma operates in the pharmaceutical industry, focusing on the development and distribution of innovative treatments for rare diseases and inflammatory conditions. The company serves a diverse client base, including underprivileged children and patients with specific medical needs. Winhealth Pharma collaborates with upstream manufacturers and other pharmaceutical companies to ensure the availability of critical medications, such as Lonafarnib for HGPS patients and treatments for inflammatory bowel disease. The company’s business model revolves around strategic partnerships and public welfare programs, which help them to make essential medications accessible to those in need. Revenue is generated through the import and distribution of these specialized drugs, as well as through collaborations with other pharmaceutical entities. Winhealth Pharma is committed to result-driven innovation, responsible practices, and entrepreneurial initiatives to continuously improve patient outcomes and address unmet medical needs.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 18.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotechnology, Disease, Biotech and Pharma, Rare Diseases, Hard Tech, DT and LS, science-based
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Aug 2018 | $10M | $40M | Kaitai Capital | — |
Growth signals
Latest recorded traffic for Weijian Pharmaceutical Group Co. is 580 monthly website visits, up 0% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Weijian Pharmaceutical Group Co. in its local ecosystem
The Weijian Pharmaceutical Group Co. office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- KCKaitai Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Weijian Pharmaceutical Group Co. on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Weijian Pharmaceutical Group Co.’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





